Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Pieter E. Postmus(University of Liverpool), Keith M. Kerr(University of Aberdeen), Matthijs Oudkerk(University Medical Center Groningen), Suresh Senan(Amsterdam UMC Location Vrije Universiteit Amsterdam), David Waller(University Hospitals of Leicester NHS Trust), Johan Vansteenkiste(KU Leuven), Carles Escriu(University of Liverpool), Solange Peters(University Hospital of Lausanne)
Annals of Oncology
May 5, 2017
10.1093/annonc/mdx222
Cited by 2,326Open Access
Full Text

Abstract

Related Papers

TNM Classification of Malignant Tumours
|Unknown|1987|16.1k
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R Aberle, Amanda M Adams, Christine D Berg et al.|New England Journal of Medicine|2011|10.9k
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al.|The Lancet Oncology|2015|2k
The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer
Pieter E. Postmus, Élisabeth Brambilla, Kari Chansky et al.|Journal of Thoracic Oncology|2007|1.6k
Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer
Jan P. van Meerbeeck, G. Kramer, Paul Van Schil et al.|JNCI Journal of the National Cancer Institute|2007|710